Monoclonal Antibody-based Vaccine Prevents Lassa Fever in Model

A combination of human monoclonal antibodies was used to protect monkeys infected with Lassa fever virus and prevented infection even when administered as late as eight days after exposure to the virus.

GLOBETECH PUBLISHING LLC